New XPrize will award $101 million to innovators who can reverse aging
The new contest aims to spur innovation into longer ‘healthspans’ with treatments that can actually reverse age-related degradation in body, mind and immune system.
Alex Knapp, Forbes Staff
This startup raised $38 million to fill one of the biggest gaps in drug discovery
Khosla Ventures-backed Vivodyne is growing human tissues in the lab to test potential new therapies before they go to clinical trials.
Brewing prescription drug ingredients like they were beer
Backed by US$120 million in venture funding, Stanford professor Christina Smolke’s company Antheia just completed its first scaled production of a key drug ingredient.
This company just raised US$71 million to see the forest for the trees within a patient’s cells
Spatial biology startup Resolve Biosciences is building up capital.
Prime Movers Lab raises a US$500 million early growth fund to invest in breakthrough science
The new fund will be focused on startups in energy, manufacturing, agriculture, healthcare, satellites and more.